Table 2. Average raw reaction times (in ms) for the different conditions in the house–face dot-probe paradigm.
|
ASD
(n=29) |
NT
(n=30) |
|||
|---|---|---|---|---|
| Placebo | Oxytocin | Placebo | Oxytocin | |
| Median (s.d.) | Median (s.d.) | Median (s.d.) | Median (s.d.) | |
| 100 ms | ||||
| Trials congruent | 463.1 (57.4) | 462.1 (50.6) | 407.8 (41.1) | 397.8 (46.3) |
| Trials incongruent | 472.9 (71.2) | 467.9 (58.1) | 415.2 (41.2) | 408.3 (39.9) |
| Filler house | 471.4 (53.2) | 474.4 (52.2) | 413.9 (37.8) | 414.7 (44.5) |
| 500 ms | ||||
| Trials congruent | 462.3 (68.6) | 444.3 (55.8) | 399.2 (38.7) | 398.5 (44.3) |
| Trials incongruent | 467.8 (65.5) | 461.6 (67.6) | 414.4 (47.7) | 413.6 (46.1) |
| Filler house | 462.3 (64.3) | 459.7 (60.3) | 418.5 (38.4) | 412.6 (43.1) |
Abbreviations: ASD, autism spectrum disorder; NT, neurotypical.